New Nanomicellar Form of Latanoprost 0,005 % in Treatment Open Angle Glaucoma
Open Access
- 28 June 2024
- journal article
- review article
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 21 (2) , 375-385
Abstract
This article provides a review of Lanpressun®, a new formulations of latanoprost micellar nanoemulsion without benzaltonium chloride (BAK). The pharmacokinetics and pharmacodynamics of new formulations are presented. Due to innovative delivery system and absence of detergent preseravative (BAK, poliquaternium and others) Lanpressun® possess better tolerability and safety to ocular surface, that provides patients adherence to longer therapy. The article presents the results of clinical trials demonstrating high hypotensive efficacy of Lanpressun®. Literature analysis of studies on safety and effect on ocular surface shows good tolerability of preservativefree latanoprost nanoemulsion. The authors give the assessment of Lanpressun® future perspectives in treatment of patients with openangle glaucomaKeywords
This publication has 31 references indexed in Scilit:
- Cyclosporine-loaded micelles for ocular delivery: Investigating the penetration mechanismsJournal of Controlled Release, 2022
- A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity studyGraefe's Archive for Clinical and Experimental Ophthalmology, 2022
- Glaucoma: Current treatment and impact of advanced drug delivery systemsLife Sciences, 2019
- TFOS DEWS II IntroductionThe Ocular Surface, 2017
- Preparation and characterization of a lutein loading nanoemulsion system for ophthalmic eye dropsJournal of Drug Delivery Science and Technology, 2016
- Primary Open-Angle Glaucoma Preferred Practice Pattern® GuidelinesOphthalmology, 2016
- Comparative Effectiveness of First-Line Medications for Primary Open-Angle GlaucomaOphthalmology, 2016
- Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivoExperimental Eye Research, 2009
- Prostamides (prostaglandin‐ethanolamides) and their pharmacologyBritish Journal of Pharmacology, 2008
- Latanoprost Exerts Neuroprotective Activity in vitro and in vivoExperimental Eye Research, 2001